Search results
Results From The WOW.Com Content Network
Never worry about your AOL services or subscriptions going past due because your financial info changed. Add, edit, or delete the payment method used for AOL products and service right from your My Account page. To access your billing info, you'll need to sign in with your Primary username and password. Add a new payment method
Hipgnosis Songs Fund Limited is a British Guernsey-registered music IP investment and song management company founded by Merck Mercuriadis and Nile Rodgers in 2018. Focused on songs and associated musical intellectual property rights, it was founded on the premise that hit songs are long-term predictable assets unaffected by economic cycles that will increase in value as the worldwide music ...
For premium support please call: 800-290-4726 more ways to reach us
In 1993, Medco Containment was acquired by Merck & Co., Inc. and became Merck-Medco. [9] [10] On October 2, 2001, UnitedHealth Group, Merck-Medco,and Accenture launched Xceleron Health LLC, a company created to deliver consulting and business acceleration services to emerging technology-based companies in the healthcare industry. [11]
2014 – Merck KGaA announced that it would purchase Sigma-Aldrich for approx. $17 billion (€13.1 billion). [16] [17] November 3, 2014 – Sigma-Aldrich filed a definitive proxy statement with the U.S. Securities and Exchange Commission to hold a special investors meeting regarding approval for the sale to Merck KGaA. [18]
On Monday, Ligand Pharmaceuticals (NAS: LGND) confirmed that Merck (NYS: MRK) will pay it a $2 million milestone payment, as the latter begins phase 2b/3 clinical trials of a new cancer drug.
The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare ...
(Reuters) -Merck & Co is nearing a $1.3 billion cash deal to buy ophthalmology biotechnology company Eyebiotech in an agreement that could see an additional $1.7 billion in milestone payments, the ...